Is preclinical data sharing the new norm?

Is preclinical data sharing the new norm? Drug Discovery Today Volume 23, Number 3 March 2018 PERSPECTIVE feature Is preclinical data sharing the new norm? Katharine A. Briggs Is preclinical data sharing the new norm? In my experience, it is certainly becoming more commonplace. However, it is not yet standard practice and remains the preserve of special projects. Here, I expound the benefits of sharing proprietary preclinical data using examples of successful initiatives. The main barriers to data sharing are then described, with suggestions for how these might be overcome. To maximise the benefits and minimise the risks involved, I suggest that organisations look to develop standard operating procedures for data sharing. Introduction Reasons for data sharing health research and aims to increase the avail- In this article, I look at the benefits and risks Benefits to public health ability and use of health research data in ways associated with sharing preclinical data. The Approximately 35% of all drug development that are equitable, ethical, and efficient (http:// projects fail as a result of toxicity detected during proprietary nature of these data means that grants.nih.gov/grants/policy/data_sharing/; preclinical safety studies [2]. Therefore, animal initiatives to share these data tend to be restricted www.mrc.ac.uk/research/research-policy-ethics/ studies are an important safeguard for http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Drug Discovery Today Elsevier

Is preclinical data sharing the new norm?

Loading next page...
 
/lp/elsevier/is-preclinical-data-sharing-the-new-norm-XmkER0mdbs
Publisher
Elsevier
Copyright
Copyright © 2016 Elsevier Ltd
ISSN
1359-6446
D.O.I.
10.1016/j.drudis.2016.05.003
Publisher site
See Article on Publisher Site

Abstract

Drug Discovery Today Volume 23, Number 3 March 2018 PERSPECTIVE feature Is preclinical data sharing the new norm? Katharine A. Briggs Is preclinical data sharing the new norm? In my experience, it is certainly becoming more commonplace. However, it is not yet standard practice and remains the preserve of special projects. Here, I expound the benefits of sharing proprietary preclinical data using examples of successful initiatives. The main barriers to data sharing are then described, with suggestions for how these might be overcome. To maximise the benefits and minimise the risks involved, I suggest that organisations look to develop standard operating procedures for data sharing. Introduction Reasons for data sharing health research and aims to increase the avail- In this article, I look at the benefits and risks Benefits to public health ability and use of health research data in ways associated with sharing preclinical data. The Approximately 35% of all drug development that are equitable, ethical, and efficient (http:// projects fail as a result of toxicity detected during proprietary nature of these data means that grants.nih.gov/grants/policy/data_sharing/; preclinical safety studies [2]. Therefore, animal initiatives to share these data tend to be restricted www.mrc.ac.uk/research/research-policy-ethics/ studies are an important safeguard for

Journal

Drug Discovery TodayElsevier

Published: Mar 1, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off